Synergy Integrative Headache Center

08/06/2025

The FDA has just approved fremanezumab (Ajovy) for the preventive treatment of episodic migraine in children and adolescents ages 6–17. This is a major step forward in giving our youngest patients access to safe, effective, and well-tolerated migraine prevention tailored to their needs. At Synergy Integrative Headache Center, we are committed to offering the most advanced and evidence-based treatments—now with even more options to help kids reclaim their energy, focus, and joy.

Teva's fremanezumab gains FDA approval for pediatric migraine prevention, offering a vital treatment option for children aged 6-17.

02/04/2025

Exciting news for people living with migraine! FDA recently approved a new medication (Symbravo) for acute migraine treatment. It utilizes a multi-mechanistic a

01/04/2025

As we welcome the New Year, I am thrilled to share some exciting news! I recently received my copy of the newly published Vagus Nerve Stimulation book, edited by Dr. Peter Staats and colleagues. It was an incredible honor to contribute a chapter titled Non-Invasive Vagus Nerve Stimulation in Migraine Treatment to this important work.

The vagus nerve plays a fascinating and vital role in many aspects of health, and vagus nerve stimulation is a promising approach for managing migraine headaches and other conditions. I’m deeply grateful to have been part of a project that sheds light on these innovative treatments.

Thank you to Peter Staats and the editorial team for the opportunity to contribute, and to everyone who continues to advance our understanding of this remarkable area of medicine.

To dive even dipper in to the field of vagus nerve visit the Vagus Nerve Society! https://www.vnsociety.org

Here’s to a year of learning, collaboration, and innovation in 2025!

https://lnkd.in/ggR4rmxG

09/12/2024

🎯 Ready to sharpen your expertise in headache medicine? 🧠 Join us in Chicago for the 15th AIHS Workshop & 13th Headache Medicine Board Review Course on October 26-27, 2024! 🚀

This exclusive event is your chance to learn from the world’s leading experts in headache medicine and pain management. Gain practical knowledge that you can apply immediately in your daily practice AND prepare for the headache medicine board exam. 📚💡

💉 What’s in store?

Master headache medicine pharmacology
Hands-on training in Botox injections for chronic migraine & cervical dystonia
Get expert guidance on peripheral nerve blocks & spinal interventions
Practice on live models and cadavers for real-world experience! 🔥
With limited seats, don’t wait—secure your spot now and elevate your career! 🙌

👉 Apply today: https://www.interventionalheadache.net/meetings-workshops/workshops/15th-wrk-13th-brd-lec?fbclid=IwY2xjawFQXH1leHRuA2FlbQIxMAABHYFfy4hDES8GIAo_2y9Loq2rbXvpjP0Un6kHImR-tBKbK00Jk1GLODUrLg_aem_4EiXtCgePFfAC929bu1o-Q

October 26-27, 2024 Chicago, IL Workshop Program Summary The program includes board review course lectures as well as hands-on / cadaver training in the following: Head and Neck Blocks Head and neck...

08/08/2024

Don't miss the 15th AIHS Workshop & 13th Headache Medicine Board Review Course!
📅 October 26-27, 2024 📍 Chicago
Seize this unique opportunity to enhance your skills in headache medicine:
• Learn the practical aspects of medication management
• Explore cutting-edge interventional treatment options
• Gain insights from internationally recognized experts in headache medicine and pain management.
This workshop offers an unparalleled hands-on experience, but seats are limited due to its interactive nature. Don't wait – register now to secure your spot!
Ideal for physicians looking to stay at the forefront of headache treatment. Whether you're preparing for board certification or seeking to refine your clinical skills, this workshop is designed for you.
Register today and take your headache and pain management practice to the next level!
https://www.interventionalheadache.net/meetings-workshops/workshops/15th-wrk-13th-brd-lec

07/18/2024

Great news for children and adolescents living with migraine. Ajovy (fremanezumab) an anti-CGRP monoclonal antibody demonstrated safety and efficacy in episodic migraine treatment among patients aged 6-17 years! Very exciting!

Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today positive topline results from its Phase 3 SPACE study evaluating the efficac

02/12/2024

On behalf of AIHS, I am thrilled to announce the 14th American Interventional Headache Society workshop and Headache Medicine Board Review course. Please join us in Chicago, IL on May 18-19, 2024. The Board Review course will cover the most clinically relevant topics in headache medicine and prepare you for the American Board of Headache Medicine examination. The hands-on workshop will cover ultrasound and fluoroscopy-guided diagnostic and therapeutic head, neck, and face interventions, as well as botulinum toxin injections for chronic migraine and cervical dystonia.
Considering the hands-on nature of the workshop, the seats are limited!
Learn more here:

May 18-19, 2024 Chicago, IL Workshop Program Summary The program includes board review course lectures as well as hands-on / cadaver training in the following: Head and Neck Blocks Head and neck...

09/14/2023

Great time and awesome experience at the International Headache Society 2023 Conference in Seoul!